Salicylate poisoning

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 11 Jan 2026
Última atualização: 06 Nov 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • ingestion of 150 mg/kg or more, or 6.5 g or more, of aspirin or aspirin equivalent
  • ingestion of methyl salicylate (oil of wintergreen)
  • ingestion of bismuth subsalicylate
  • self-harm or suicide attempt
  • children age 3 years or younger, and adults age 70 years or older
  • unknown toxin ingestion or exposure
  • abnormal behavior
  • nausea, vomiting, hematemesis, epigastric pain
  • fever and diaphoresis
  • shortness of breath
  • tachypnea, Kussmaul respirations
  • tinnitus and/or deafness
  • malaise and/or dizziness
  • movement disorders, asterixis, stupor
  • confusion and/or delirium (irritability, hallucinations)
  • coma and/or papilledema
  • seizures
  • rales plus low oxygen saturation
Detalhes completos

Outros fatores diagnósticos

  • volume depletion
  • skin rash
Detalhes completos

Fatores de risco

  • ingestion of 150 mg/kg or more, or 6.5 g or more, of aspirin or aspirin equivalent
  • ingestion of methyl salicylate (oil of wintergreen)
  • ingestion of bismuth subsalicylate
  • history of self-harm or suicide attempt
  • children age 3 years or younger, and adults age 70 years or older
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • ABG
  • serum electrolyte panel
  • serum salicylate level
  • serum BUN and creatinine
  • serum ketones
  • blood glucose
  • CBC
  • serum LFTs
  • serum PT, activated PTT, INR
  • toxicology screen
  • chest x-ray
  • ECG
Detalhes completos

Investigações a serem consideradas

  • echocardiogram
  • head CT scan
  • EEG
Detalhes completos

Algoritmo de tratamento

AGUDA

asymptomatic: without criteria for emergency department evaluation

asymptomatic: with criteria for emergency department evaluation

symptomatic

Colaboradores

Consultores especialistas

Chris Hoyte, MD

Medical Toxicology Fellowship Program Director

Rocky Mountain Poison and Drug Safety

Denver

Professor

Department of Emergency Medicine

University of Colorado School of Medicine

Aurora

CO

Declarações

CH declares that he has no competing interests.

Eric Lavonas, MD, MS

Attending Physician

Department of Emergency Medicine and Rocky Mountain Poison and Drug Safety

Denver Health

Denver

Professor

Department of Emergency Medicine

University of Colorado School of Medicine

Aurora

CO

Declarações

EL is an author of a reference cited in this topic.

Agradecimentos

Dr Chris Hoyte and Dr Eric Lavonas would like to gratefully acknowledge Dr Kathryn A. Koch, a previous contributor to this topic.

Declarações

KAK declares that she has no competing interests.

Revisores

Colin A. Graham, MBChB, MPH, MD, FRCSEd, FRCSGlasg, FIMCRCSEd, FCCP, FCEM, FHKCEM, FHKAM

Editor

European Journal of Emergency Medicine

Professor of Emergency Medicine

Chinese University of Hong Kong

Hong Kong

People's Republic of China

Declarações

CAG is the editor of the European Journal of Emergency Medicine and receives an annual honorarium from Wolters Kluwer Health, the journal's publishers.

Gerald F. O'Malley, DO

Director

Division of Research

Department of Emergency Medicine

Albert Einstein Medical Center

Philadelphia

PA

Declarações

GFOM declares that he has no competing interests.

Paul Wax, MD

Clinical Professor of Surgery (Emergency Medicine)

University of Texas Southwestern Medical Center

Dallas

TX

Declarações

PW is an author of a reference cited in this topic.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Palmer BF, Clegg DJ. Salicylate toxicity. N Engl J Med. 2020 Jun 25;382(26):2544-55. Resumo

Chyka PA, Erdman AR, Christianson G, et al. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(2):95-131.Texto completo  Resumo

American College of Medical Toxicology. Guidance document: management priorities in salicylate toxicity. J Med Toxicol. 2015 Mar;11(1):149-52.Texto completo  Resumo

Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J. 2002 May;19(3):206-9.Texto completo  Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Salicylate poisoning images
  • Diagnósticos diferenciais

    • Diabetic ketoacidosis
    • Dementia
    • Pneumonia
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Salicylates poisoning
    • Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management
    Mais Diretrizes
  • Calculadoras

    Anion Gap

    Mais Calculadoras
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal